Cannabis and Pelvic Pain

Not Medical Advice

This article is not medical advice. It summarizes published evidence and survey data. Pelvic pain has many causes — endometriosis, adenomyosis, fibroids, interstitial cystitis, pelvic floor dysfunction, nerve entrapment, cancer, infection — and several of them are serious and treatable. If you have new, severe, or worsening pelvic pain, see a clinician before self-treating with cannabis or anything else. Cannabis interacts with some medications and is not appropriate for everyone, especially during pregnancy.

Plain-Language Summary

Pelvic pain is a broad category that includes period pain (dysmenorrhea), endometriosis, vulvodynia, bladder pain syndrome, and chronic pelvic pain of unclear cause. Standard treatments — NSAIDs, hormonal therapies, neuromodulators, physical therapy, surgery — work well for some people and poorly for others.

A growing number of patients use cannabis for pelvic pain, and surveys consistently show most users report meaningful relief ^[1][2][3]. The catch: surveys ask people who already use cannabis whether they think it helps. That's useful signal, but it's not proof. Rigorous controlled trials in pelvic pain are nearly nonexistent. One small randomized trial in chronic pelvic pain found vaporized cannabis reduced pain compared to placebo ^[4]. That's it for high-quality data.

So cannabis is a reasonable thing to try for refractory pelvic pain, but the evidence base is much thinner than the enthusiasm suggests.

What Probably Works

Short-term symptom relief in chronic pelvic pain. A 2023 randomized, double-blind, placebo-controlled crossover trial in women with chronic pelvic pain found vaporized cannabis (THC-dominant) reduced pain intensity versus placebo over a single dosing session Weak / limited^[4]. This is the strongest pelvic-pain-specific trial we have, but it's small and short.

Pain and sleep in endometriosis (self-reported). Multiple surveys — including a large Australian cohort ^[1] and a New Zealand survey ^[2] — report that roughly 60–95% of cannabis-using endometriosis patients rate it 'effective' for pain, sleep, nausea, and mood Weak / limited. People often report reducing their use of other medications, including opioids.

General chronic pain. Cannabis has moderate evidence for chronic non-cancer pain overall, per the 2017 National Academies report Strong evidence^[5]. Pelvic pain wasn't analyzed separately, but it's reasonable to expect the class effect applies.

What Might Work

Dysmenorrhea (period pain). Survey data suggests cannabis users find it helpful for menstrual pain Weak / limited^[3]. No controlled trials. Historically, 19th-century Western medicine prescribed cannabis tinctures for dysmenorrhea Anecdote^[6], which is interesting historical context but not evidence.

Pelvic floor muscle spasm. THC has antispasticity effects in multiple sclerosis Strong evidence^[5]. Whether this extrapolates to pelvic floor hypertonicity is unstudied No data, but it's biologically plausible.

Topical/vaginal CBD or THC products. A booming market with almost no controlled human data. One small open-label study of CBD suppositories in endometriosis showed self-reported improvement Weak / limited, but without a placebo arm this tells us very little. Vaginal absorption of cannabinoids is poorly characterized.

What Doesn't Work or Has Weak Evidence

CBD-only products for moderate-to-severe pelvic pain. Survey respondents who used THC-containing products generally reported more relief than CBD-only users Weak / limited^[1]. Isolated CBD at typical consumer doses (10–50 mg) has not shown convincing analgesic effects in controlled pain trials Disputed.

Cannabis as a disease-modifying treatment for endometriosis. There is no evidence cannabis shrinks endometriotic lesions or alters disease progression in humans No data. Mouse studies show cannabinoid receptors are involved in lesion biology ^[7], but this is preclinical and does not translate to clinical claims.

'Indica for pain, sativa for energy.' This is marketing folklore, not a clinically useful distinction Disputed. Chemotype (cannabinoid and terpene profile) matters more than the indica/sativa label. See Indica vs Sativa.

What We Don't Know

• Optimal dose, route, and cannabinoid ratio for any specific pelvic pain condition.
• Whether daily cannabis use prevents flares or only treats them acutely.
• Long-term effects of chronic use in patients with endometriosis specifically (most safety data is from general populations).
• Whether vaginal/rectal cannabinoid products actually deliver clinically meaningful drug levels.
• Interactions with hormonal contraceptives, GnRH agonists, and other endometriosis medications.
• Effects on fertility — relevant because many pelvic pain patients are trying to conceive Disputed^[8].

Comparison With Standard Treatments

NSAIDs (ibuprofen, naproxen, mefenamic acid): First-line for dysmenorrhea, well-studied, cheap. Cannabis has not been shown to outperform NSAIDs and shouldn't replace them as first-line Strong evidence^[9].

Hormonal therapy (combined pills, progestins, GnRH analogs): Can suppress endometriosis lesions and reduce pain. Disease-modifying in a way cannabis is not. Side effect profiles differ — some patients tolerate one and not the other.

Surgery (laparoscopic excision): Can provide durable relief for endometriosis. Cannabis is not a substitute for surgical management of confirmed lesions causing organ dysfunction.

Pelvic floor physical therapy: Strong evidence for myofascial pelvic pain and vulvodynia. Cannabis may complement but does not replace it.

Opioids: Surveys suggest many cannabis users reduce opioid use Weak / limited^[1]. This is one of the more interesting potential benefits, given opioid risks, though the displacement effect is not proven in randomized trials for pelvic pain.

Risks and Practical Considerations

• Pregnancy: Avoid. Cannabis use in pregnancy is associated with lower birth weight and possible neurodevelopmental effects Strong evidence^[10]. Many pelvic pain patients are of reproductive age — this matters.
• Cannabinoid hyperemesis syndrome (CHS): Chronic heavy use can cause cyclic vomiting and abdominal pain that mimics a pelvic pain flare. See Cannabinoid Hyperemesis Syndrome.
• Dependence: Roughly 1 in 10 adult users develop cannabis use disorder; risk is higher with daily use Strong evidence^[5].
• Cognitive and driving impairment with THC-containing products.
• Drug interactions: CBD inhibits CYP enzymes and can raise levels of some medications.
• Cost and access: Medical cannabis is rarely covered by insurance. Out-of-pocket costs can exceed standard treatments.
• Practical tip: If trying cannabis for pelvic pain, most clinicians experienced with medical cannabis suggest starting low (e.g., 2.5 mg THC oral or a single small inhaled dose), titrating slowly, and tracking symptoms in a diary. Discuss with a clinician familiar with both your gynecologic condition and cannabis.

Sources

How this page was made

Related

• Cannabis and Chronic Pain — What the evidence actually says about cannabis for long-term pain, separated from the mark...